![Becker Hewes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Becker Hewes
Technik-/Wissenschafts-/F&E-Leiter bei
DAMORA THERAPEUTICS, INC.
Vermögen: 7 Mio $ am 31.05.2026
Profil
Becker Hewes ist Chief Medical Officer bei Blueprint Medicines Corp. In seiner früheren Karriere war Dr. Hewes Chief Medical Officer bei Repertoire Immune Medicines, Inc. und Executive Director-Translational Clinical Oncology bei Novartis Institutes for Biomedical Research, Inc. Er promovierte an der Georgetown University School of Medicine und erwarb einen Bachelor-Abschluss an der Vanderbilt University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.01.2026 | 264’629 ( 0.43% ) | 7 Mio $ | 31.05.2026 |
Aktive Positionen von Becker Hewes
| Unternehmen | Position | Beginn |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.01.2026 |
Ehemalige bekannte Positionen von Becker Hewes
| Unternehmen | Position | Ende |
|---|---|---|
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01.02.2017 |
| BLUEPRINT MEDICINES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Becker Hewes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
